首页> 外国专利> Gellable pharmaceutical compositions comprising active substance, phospholipid, solvent and fatty acid and their use for the controlled release of one or more active substances by subcutaneous and/or intramuscular injection

Gellable pharmaceutical compositions comprising active substance, phospholipid, solvent and fatty acid and their use for the controlled release of one or more active substances by subcutaneous and/or intramuscular injection

机译:包含活性物质,磷脂,溶剂和脂肪酸的可胶凝药物组合物及其通过皮下和/或肌内注射控制释放一种或多种活性物质的用途

摘要

A fluid pharmaceutical composition which allows the release of at least one active substance and which comprises: i) A therapeutically effective amount of at least one active substance; ii) From 3 to 55% by weight of phospholipid; iii) From 16 to 72% by weight of pharmaceutically acceptable solvent; and iv) From 4 to 52% by weight of fatty acid; The composition has the property of gelling instantaneously in the presence of an aqueous phase. The above described pharmaceutical composition is useful for the controlled release of one or more substances by subcutaneous and/or intramuscular injection wherein the medicament has the property of gelling instantaneously in the presence of an aqueous phase.
机译:允许释放至少一种活性物质的流体药物组合物,其包含:i)治疗有效量的至少一种活性物质; ii)3至55重量%的磷脂; iii)16至72重量%的药学上可接受的溶剂; iv)4至52重量%的脂肪酸​​;该组合物具有在水相存在下瞬间胶凝的性质。上述药物组合物可用于通过皮下和/或肌内注射来控制释放一种或多种物质,其中药物具有在水相存在下瞬间胶凝的特性。

著录项

  • 公开/公告号NZ507707A

    专利类型

  • 公开/公告日2002-05-31

    原文格式PDF

  • 申请/专利权人 UCB S;

    申请/专利号NZ19990507707

  • 申请日1999-04-16

  • 分类号A61K9/10;A61K47/12;A61K47/24;A61K47/44;

  • 国家 NZ

  • 入库时间 2022-08-22 00:44:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号